logo for MDT

MDT • NYSE

Medtronic Plc

$87.75

+ Add to Watchlist

Stock Details

Market Cap 112,324,387,500
Day Change 2.24 (2.62%)
Volume 105,663,236
Avg Volume 11,359,263
Price Range 73.31-106.33

Overview

Country IE
Sector Healthcare
Industry Medical - Devices
Exchange NYSE

Company Profile

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Financial Overview

52 Week High 106.33
52 Week High Date 2025-11-26
52 Week Low 73.31
52 Week Low Date 2026-06-02
10D Avg Trading Vol 26.36442
YTD Price Return Daily -9.3379
MTD Price Return Daily 0.9271

Cash Flow

TTM/Share 4.76864
Annual/Share 4.2393
Quarterly/Share 4.7912

Price-to-Earnings

Annual Ratio 2.1262
Quarterly Ratio 2.0671
TTM 21.3296

Revenue

3Y Growth 5.21
5Y Growth 3.84
Annual/Share 13.73
TTM/Share 29.2125
5Y Share Growth 4.88

Earnings Per Share

Annual 3.7264
3Y Growth 9.74
5Y Growth 6.95
Quarterly YOY Growth 41.67

Price-to-Book

Ratio 2.222
Annual Ratio 2.1627
TTM 2.176